- Cell Therapeutics (CTIC +8.3%) initiated at Buy at Wainwright. Price target is $4.
- Evoke Pharma (EVOK +2.1%) initiated at Buy at Cantor. Price target is $19.
- MacroGenics (MGNX +0.8%) initiated at Leerink and BofA at Outperform and Neutral respectively. Price targets are $34 and $30.
- AstraZeneca (AZN +0.1%) cut to Neutral from Buy at UBS.
- WellCare Health Plans (WCG -0.6%) cut to Neutral from Buy at Monness Crespi.
- Teva (TEVA -0.9%) cut to Underweight from Neutral at JPMorgan. Price target to $38 from $43.
Healthcare downgrades and initiations for Monday
Nov 4 2013, 09:45 ET